Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
Lin HM, Mak B, Yeung N, Huynh K, Meikle TG, Mellett NA, Kwan EM, Fettke H, Tran B, Davis ID, Mahon KL, Zhang A, Stockler MR, Briscoe K, Marx G, Crumbaker M, Stricker PD, Du P, Yu J, Jia S, Scheinberg T, Fitzpatrick M, Bonnitcha P, Sullivan DR, Joshua AM, Azad AA, Butler LM, Meikle PJ, Horvath LG.
EBioMedicine. 2021 Oct 14;72:103625. doi: 10.1016/j.ebiom.2021.103625. PMID: 34656931.
Contact: Lisa Butler
Prostate cancer: The impact of family history
Survival outcomes in men with a positive family history of prostate cancer: a registry based study
Ang M, Borg M, O'Callaghan ME; South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC). BMC Cancer. 2020 Sep 18;20(1):894. doi: 10.1186/s12885-020-07174-9.
Contact: Michael O’Callaghan